drugset
Drugs / Midazolam Hcl 1Mg/Ml Inj
last change Aug 2023 re-read 3 minutes ago

Midazolam Hcl 1Mg/Ml Inj

Investigated by
National Center for Complementary and Integrative Health (NCCIH) · Washington State University

Trials 1

today NCT05081583 · Ph 0
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT05081583 Sep 2021 → Jan 2023 type 2 diabetes mellitus Washington State University Completed Met primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Midazolam Hcl 1Mg/Ml Inj ClinicalTrials.gov intervention name — accepted as the source's own label NCT05081583 ↗
Route Intravenous “administered a single dose of midazolam (0.5 mg) intravenously” NCT05081583 ↗